Aptar Requests U.S. FDA Emergency Use Authorization for N95 Filtering Facepiece Respirator Decontamination with ActivShield™.


Growing Confidence in Airless Dispensing

Read description


In recent years, the market of drugs using the topical application route has been growing considerably. Using the human skin to distribute medication to the patient’s body attracts drug developers for its improved safety and convenient use. Consequently, the number of formulations for dermal application is growing continuously. Challenging bulks, increasing regulatory requirements, the need to differentiate in a crowded marketplace, and a patient centered view are raising the bar for pharmaceutical packaging.

A couple billion skin drug units are sold every year, the majority in basic primary packaging. Tubes, jars and bottles are well known but lack addressing urgent demands in modern packaging development. Advanced airless dispensing systems have been introduced into the pharmaceutical market quite some time ago. Up to now, their use is limited to demanding niche products.

This is somewhat surprising as there is a large standard range of airless systems as well as innovative solutions available. Those can support increasing market demands for expert pharmaceutical packaging. Moreover, there are references established on all major regulated markets. Key providers of airless technology have built enough expertise to support drug development projects all the way through to a successful registration and launch.

While attending this Webinar you will learn about market trends in topical dermatology drug dispensing and why Airless Dispensing is a modern solution for topical product packaging. Register today to understand how Aptar Pharma’s Airless Dispensing Solutions and expert services can help to make your drug development project a success.

Presented by

Dr. Stefan Hellbardt VP Business Development
Dr. Stefan Hellbardt is Vice President Business Development at Aptar Pharma. As a trained biologist, he earned his PhD at the German Cancer Research Center, Heidelberg. Holding various positions in the pharmaceutical industry, he gained more than 15 years of experience in clinical development. Stefan Hellbardt joined Aptar Pharma in 2011 to lead the global business development of the application field of Dermal Drug Delivery. In his role, he is instrumental in delivering the expertise and service of Aptar to customers developing pharmaceutical products for topical dermal and transdermal applications.
Thomas Hauser Director Business Development, Pharma and Healthcare
Thomas Hauser is Director Business Development at Aptar Pharma. After training and education in Germany, France and Canada he worked in positions with increasing responsibility for business development and sales teams in international companies. Thomas Hauser has a strong background in flexibles, films and other primary packaging. He is a recognized expert in elastomer compounds for the pharmaceutical industry. Within the last years he was responsible for establishing and growing the pharma business for Airless Dispensing Systems globally. It was his mission to set up the Healthcare Division in Mega Airless. After acquisition by Aptar he supported the smooth integration into the Aptar organization ensuring continuous growth of the Airless Dispensing offer for customers of Aptar Pharma.
Please register to view the webinar :Already registered ?
Mandatory fields

*The information marked with (*) is essential to process your request. Failure to provide such information may prevent us from fulfilling your request. Your personal data will be used only for Aptar to process an information request and/or job application and will be made accessible to Aptar and to any third party for exclusively technical and logistical reasons, notably to our services located outside the European Union, being specified that, in the event that the recipient country does not ensure a level of data protection equivalent to that of the European Union, Aptar undertakes to take all relevant guarantees, either on the basis of an adequacy decision or, in the absence of such a decision, on the basis of appropriate safeguards, a copy of which may be requested from the contact email below. Your personal data will only be kept for a period that does not exceed the applicable statutory limitation periods. Any contact data will be made accessible to Aptar and to third parties that provide technical and logistical support to Aptar for the purpose of your contact request.

If any after communication upon receipt of a valid identity document, you have the right to access, modify, rectify, limit, delete and ask, if any, the portability of your personal data as well as a right of opposition, if necessary subject to legitimate and imperative reasons, to the processing of such data. You may also define guidelines for the use of your personal data in the event of death.

If you wish to exercise this option or if you have any questions regarding our General Terms and Conditions of Use, Privacy and Cookies Policy, please contact Aptar at: informationgovernance@aptar.com

You also have the right to lodge a complaint at the relevant data protection authority in your own jurisdiction.

March 14, 2017 2pm London / 10 am New York 60 min
Watch now
Presented by
Dr. Stefan Hellbardt VP Business Development
Thomas Hauser Director Business Development, Pharma and Healthcare
Read more
Key Learning Objectives
  • Understand the principles of Airless Dispensing
  • Benefits of Airless Dispensing for administration of skin products
  • Learn about products available for Airless Dispensing
  • Understand key success elements in the support of development projects using Airless Dispensing
Do you have questions about this webinar ?
Contact us